S

Superluminal Medicines

ML-driven design of candidate small molecules

Senior Scientist - Discovery Biology

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeBoston, MA, USA

About the Job

Requirements

  • A Ph.D. in Biology or a related life sciences field and at least five years of relevant industry experience are required.
  • Demonstrated hands-on experience developing, executing, and interpreting cell-based assays using multiple assay formats and platforms, including functional assays, target engagement assays, kinetic assays, plate-based assays, flow cytometry, and high-content imaging.
  • Small molecule drug discovery experience is required.
  • Demonstrated problem-solving skills and the ability to develop innovative solutions to complex challenges are required.

Responsibilities

  • Drive programs from hit finding through all phases of early discovery through hands-on, wet-lab-focused work.
  • Independently design, develop, and execute a broad array of cell-based assays to interrogate GPCR function and signaling.
  • Generate, analyze, document, and upload experimental and routine screening data to company databases in a timely and accurate manner.
  • Collaborate with computational, chemistry, and protein science colleagues to conceptualize, design, and execute novel screening assays.
  • Regularly communicate findings with program teams and present at project and company-wide meetings.
  • Ensure compliance with established laboratory practices, standard operating procedures, and company policies, including wet-lab and electronic data-management requirements.
  • Lead from the bench and contribute to biology strategy and execution across company programs.

Desired Qualifications

  • Experience with GPCR biology is highly desired.
  • Experience with assay automation, high-throughput screening, or laboratory robotics is a plus.
  • Management experience is a plus.

About the Company

Superluminal Medicines

ML-driven design of candidate small molecules

Superluminal Medicines develops small-molecule drug discovery solutions by combining deep biology, chemistry, and machine learning. It creates candidate-ready compounds with high speed and accuracy, using a proprietary big data platform and predictive design models to model protein shapes and design selective compounds that induce precise structural changes for therapeutic effects. The company collaborates with pharmaceutical and biotech firms, licensing its technology and pursuing milestone-based payments, rather than selling products outright. This partnership-centric model helps clients accelerate their drug discovery programs in a highly competitive market. The company aims to shorten the path from target to clinical candidate by delivering well-characterized, selective small molecules efficiently.

Company size
51-200
Company stage
Series B
Total funding
$213M
Headquarters
Boston, MA
Founded
2023

Recently Posted Jobs

Explore more opportunities at Superluminal Medicines

See more jobs